CoChat
Sign Up
Cited by 66

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells

Guryanova, O A, Lieu, Y K, Garrett-Bakelman, F E, Spitzer, B, Glass, J L, Shank, K, Martinez, A B V, Rivera, S A, Durham, B H, Rapaport, F, Keller, M D, Pandey, S, Bastian, L, Tovbin, D, Weinstein, A R, Teruya-Feldstein, J, Abdel-Wahab, O, Santini, V, Mason, C E, Melnick, A M, Mukherjee, S, Levine, R L·2016·Leukemia
DOI 10.1038/leu.2015.358PMC PMC4856586
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/leu.2015.358

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 42

  1. Shih AH, Abdel-Wahab O, Patel JP, Levine RL . The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer 2012; 12: 599–612. · DOI · Paper page
  2. Abdel-Wahab O, Pardanani A, Rampal R, Lasho TL, Levine RL, Tefferi A . DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms. Leukemia 2011; 25: 1219–1220. · DOI · Paper page
  3. Stegelmann F, Bullinger L, Schlenk RF, Paschka P, Griesshammer M, Blersch C et al. DNMT3A mutations in myeloproliferative neoplasms. Leukemia 2011; 25: 1217–1219. · DOI · Paper page
  4. Walter MJ, Ding L, Shen D, Shao J, Grillot M, McLellan M et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 2011; 25: 1153–1158. · DOI · Paper page
  5. Yan XJ, Xu J, Gu ZH, Pan CM, Lu G, Shen Y et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet 2011; 43: 309–315. · DOI
  6. Patel JP, Gonen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. New Engl J Med 2012; 366: 1079–1089. · DOI
  7. Kim SJ, Zhao H, Hardikar S, Singh AK, Goodell MA, Chen T . A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells. Blood 2013; 122: 4086–4089. · DOI · Paper page
  8. Meldi K, Qin T, Buchi F, Droin N, Sotzen J, Micol JB et al. Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia. J Clin Invest 2015; 125: 1857–1872. · DOI
  9. Bejar R, Levine R, Ebert BL . Unraveling the molecular pathophysiology of myelodysplastic syndromes. J Clin Oncol 2011; 29: 504–515. · DOI
  10. Challen GA, Sun D, Jeong M, Luo M, Jelinek J, Berg JS et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 2011; 44: 23–31. · DOI · Paper page
  11. Mayle A, Yang L, Rodriguez B, Zhou T, Chang E, Curry CV et al. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. Blood 2015; 125: 629–638. · DOI · Paper page
  12. Nguyen S, Meletis K, Fu D, Jhaveri S, Jaenisch R . Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan. Dev Dynamics 2007; 236: 1663–1676. · DOI
  13. Yusuf RZ, Scadden DT . Homing of hematopoietic cells to the bone marrow. J Vis Exp 2009; (25): pii:1104. · DOI
  14. Garrett-Bakelman FE, Sheridan CK, Kacmarczyk TJ, Ishii J, Betel D, Alonso et al. Enhanced reduced representation bisulfite sequencing for assessment of DNA methylation at base pair resolution. J Vis Exp 2015; (96): e52246. · DOI
  15. Chen K, Liu J, Heck S, Chasis JA, An X, Mohandas N . Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci USA 2009; 106: 17413–17418. · DOI
  16. Socolovsky M, Nam H, Fleming MD, Haase VH, Brugnara C, Lodish HF . Ineffective erythropoiesis in Stat5a(−/−)5b(−/−) mice due to decreased survival of early erythroblasts. Blood 2001; 98: 3261–3273. · DOI
  17. Joseph C, Quach JM, Walkley CR, Lane SW, Lo Celso C, Purton LE . Deciphering hematopoietic stem cells in their niches: a critical appraisal of genetic models, lineage tracing, and imaging strategies. Cell Stem Cell 2013; 13: 520–533. · DOI
  18. Kuhn R, Schwenk F, Aguet M, Rajewsky K . Inducible gene targeting in mice. Science 1995; 269: 1427–1429. · DOI · Paper page
  19. Day BW, Stringer BW, Spanevello MD, Charmsaz S, Jamieson PR, Ensbey KS et al. ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1. Neurooncology 2011; 13: 1202–1212.
  20. Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M . Cancer genetics and genomics of human FOX family genes. Cancer Lett 2013; 328: 198–206. · DOI
  21. Lim JH . Zinc finger and BTB domain-containing protein 3 is essential for the growth of cancer cells. BMB Rep 2014; 47: 405–410. · DOI
  22. Laurenti E, Wilson A, Trumpp A . Myc's other life: stem cells and beyond. Curr Opin Cell Biol 2009; 21: 844–854. · DOI
  23. Okita K, Yamanaka S . Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Curr Stem Cell Res Ther 2006; 1: 103–111. · DOI
  24. Guryanova OA, Wu Q, Cheng L, Lathia JD, Huang Z, Yang J et al. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 2011; 19: 498–511. · DOI
  25. Will B, Vogler TO, Bartholdy B, Garrett-Bakelman F, Mayer J, Barreyro L et al. Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitment. Nat Immunol 2013; 14: 437–445. · DOI
  26. Golubkov VS, Prigozhina NL, Zhang Y, Stoletov K, Lewis JD, Schwartz PE et al. Protein-tyrosine pseudokinase 7 (PTK7) directs cancer cell motility and metastasis. J Biol Chem 2014; 289: 24238–24249. · DOI
  27. Heit C, Jackson BC, McAndrews M, Wright MW, Thompson DC, Silverman GA et al. Update of the human and mouse SERPIN gene superfamily. Hum Genomics 2013; 7: 22. · DOI
  28. Worzfeld T, Offermanns S . Semaphorins and plexins as therapeutic targets. Nat Rev Drug Discov 2014; 13: 603–621. · DOI
  29. Chambers SM, Boles NC, Lin KY, Tierney MP, Bowman TV, Bradfute SB et al. Hematopoietic fingerprints: an expression database of stem cells and their progeny. Cell Stem Cell 2007; 1: 578–591. · DOI
  30. He S, Kim I, Lim MS, Morrison SJ . Sox17 expression confers self-renewal potential and fetal stem cell characteristics upon adult hematopoietic progenitors. Genes Dev. 2011; 25: 1613–1627. · DOI
  31. Ribeiro AF, Pratcorona M, Erpelinck-Verschueren C, Rockova V, Sanders M, Abbas S et al. Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia. Blood 2012; 119: 5824–5831. · DOI
  32. Pietras EM, Lakshminarasimhan R, Techner JM, Fong S, Flach J, Binnewies M et al. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J Exp Med 2014; 211: 245–262. · DOI · Paper page
  33. Mirantes C, Passegue E, Pietras EM . Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. Exp Cell Res 2014; 329: 248–254. · DOI · Paper page
  34. Will B, Zhou L, Vogler TO, Ben-Neriah S, Schinke C, Tamari R et al. Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations. Blood 2012; 120: 2076–2086. · DOI
  35. Elias HK, Schinke C, Bhattacharyya S, Will B, Verma A, Steidl U . Stem cell origin of myelodysplastic syndromes. Oncogene 2014; 33: 5139–5150. · DOI
  36. Babovic S, Eaves CJ . Hierarchical organization of fetal and adult hematopoietic stem cells. Exp Cell Res 2014; 329: 185–191. · DOI
  37. Mikkola HK, Orkin SH . The journey of developing hematopoietic stem cells. Development 2006; 133: 3733–3744. · DOI
  38. Johns JL, Christopher MM . Extramedullary hematopoiesis: a new look at the underlying stem cell niche, theories of development, and occurrence in animals. Vet Pathol 2012; 49: 508–523. · DOI
  39. Lee WY, Kubes P . Leukocyte adhesion in the liver: distinct adhesion paradigm from other organs. J Hepatol 2008; 48: 504–512. · DOI
  40. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 2001; 276: 43503–43508. · DOI
  41. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109: 625–637. · DOI
  42. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K . Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006; 20: 1123–1136. · DOI

Cited by

Metadata

Authors
Guryanova, O. A., Lieu, Y. K., Garrett-Bakelman, F. E., Spitzer, B., Glass, J. L., Shank, K., Martinez, A. B. V., Rivera, S. A., Durham, B. H., Rapaport, F., Keller, M. D., Pandey, S., Bastian, L., Tovbin, D., Weinstein, A. R., Teruya-Feldstein, J., Abdel-Wahab, O., Santini, V, Mason, C. E., Melnick, A. M., Mukherjee, S., & Levine, R. L.
Venue
Leukemia
Publisher
Springer Science and Business Media LLC
Published
2015-12-29
Volume
30
Issue
5
Pages
1133-1142
ISSN
  • 0887-6924
  • 1476-5551
DOI
10.1038/leu.2015.358
PMC
PMC4856586
Cited by
66
References
9
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review